AI-Driven Analysis of Advanced Imaging Biomarkers for In-Depth Brain Tumor Assessment


This webinar is brought to you by GLiMR COST Action together with Cercare Medical. This is a recording of the live session that is now available on-demand.

Join us with Professor Kim Beuschau Mouridsen, Dr. Mikkel Bo Hansen, and Dr. Ronald Borra, MD, for an introduction to new unique perfusion biomarkers (CTH, OEF, CMRO2) that are derived from routine dynamic imaging protocols and that have been shown to provide important insights into brain tissue metabolism.

Additionally, they briefly talk about how these biomarkers are currently used for training an AI algorithm targeted at improving brain tumor grading and prognosis.


About Kim Mouridsen

Kim Beuschau Mouridsen, PhD, founder and Managing Director at Cercare Medical

Mikkel Bo Hansen

Mikkel Bo Hansen, PhD, founder and CSO at Cercare Medical

Ronald Borra

Ronald Borra, MD, PhD, CMO at Cercare Medical

Sign up for the webinar here

Cercare Medical ApS
Inge Lehmanns Gade 10
Office 07.016
DK-8000 Aarhus C

Privacy Policy